Standard BioTools Operating Margin 2010-2025 | LAB

Current and historical operating margin for Standard BioTools (LAB) over the last 10 years. The current operating profit margin for Standard BioTools as of March 31, 2025 is -63.67%.
Standard BioTools Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $0.17B $-0.15B -87.65%
2024-12-31 $0.18B $-0.18B -100.57%
2024-09-30 $0.16B $-0.16B -105.13%
2024-06-30 $0.14B $-0.15B -112.50%
2024-03-31 $0.13B $-0.12B -93.70%
2023-12-31 $0.11B $-0.08B -71.70%
2023-09-30 $0.11B $-0.08B -72.38%
2023-06-30 $0.11B $-0.08B -79.25%
2023-03-31 $0.10B $-0.11B -109.28%
2022-12-31 $0.10B $-0.12B -118.18%
2022-09-30 $0.11B $-0.11B -97.27%
2022-06-30 $0.11B $-0.10B -86.73%
2022-03-31 $0.13B $-0.08B -60.80%
2021-12-31 $0.13B $-0.07B -51.15%
2021-09-30 $0.14B $-0.07B -52.90%
2021-06-30 $0.15B $-0.06B -38.93%
2021-03-31 $0.14B $-0.06B -38.19%
2020-12-31 $0.14B $-0.05B -36.69%
2020-09-30 $0.13B $-0.04B -34.13%
2020-06-30 $0.11B $-0.05B -46.43%
2020-03-31 $0.11B $-0.05B -46.49%
2019-12-31 $0.12B $-0.05B -44.83%
2019-09-30 $0.12B $-0.05B -46.55%
2019-06-30 $0.12B $-0.05B -43.70%
2019-03-31 $0.12B $-0.05B -42.74%
2018-12-31 $0.11B $-0.05B -43.75%
2018-09-30 $0.11B $-0.05B -43.52%
2018-06-30 $0.10B $-0.05B -49.04%
2018-03-31 $0.10B $-0.05B -52.94%
2017-12-31 $0.10B $-0.06B -57.28%
2017-09-30 $0.10B $-0.07B -68.00%
2017-06-30 $0.10B $-0.07B -72.16%
2017-03-31 $0.10B $-0.07B -71.29%
2016-12-31 $0.10B $-0.07B -70.19%
2016-09-30 $0.11B $-0.07B -62.73%
2016-06-30 $0.12B $-0.06B -50.43%
2016-03-31 $0.12B $-0.06B -47.46%
2015-12-31 $0.12B $-0.05B -43.97%
2015-09-30 $0.12B $-0.05B -39.83%
2015-06-30 $0.12B $-0.05B -43.70%
2015-03-31 $0.12B $-0.05B -41.53%
2014-12-31 $0.12B $-0.05B -44.44%
2014-09-30 $0.11B $-0.05B -44.76%
2014-06-30 $0.09B $-0.04B -41.94%
2014-03-31 $0.08B $-0.03B -37.80%
2013-12-31 $0.07B $-0.02B -26.76%
2013-09-30 $0.07B $-0.02B -25.76%
2013-06-30 $0.06B $-0.02B -26.23%
2013-03-31 $0.06B $-0.02B -28.07%
2012-12-31 $0.05B $-0.02B -32.08%
2012-09-30 $0.05B $-0.02B -34.00%
2012-06-30 $0.05B $-0.02B -35.42%
2012-03-31 $0.05B $-0.02B -43.48%
2011-12-31 $0.04B $-0.02B -43.18%
2011-09-30 $0.04B $-0.02B -43.90%
2011-06-30 $0.04B $-0.02B -44.74%
2011-03-31 $0.04B $-0.01B -40.00%
2010-12-31 $0.03B $-0.01B -42.42%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.501B $0.174B
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.618B 59.31
Hims & Hers Health (HIMS) United States $14.180B 117.32
Doximity (DOCS) United States $10.950B 50.70
Tempus AI (TEM) United States $9.958B 0.00
IRhythm Technologies (IRTC) United States $5.300B 0.00
Inspire Medical Systems (INSP) United States $3.833B 56.50
Hinge Health (HNGE) United States $3.762B 0.00
Privia Health (PRVA) United States $2.374B 162.25
10x Genomics (TXG) United States $1.684B 0.00
Phreesia (PHR) United States $1.623B 0.00
Enovis (ENOV) United States $1.521B 8.48
Azenta (AZTA) United States $1.484B 68.96
Schrodinger (SDGR) United States $1.467B 0.00
Clover Health Investments (CLOV) United States $1.466B 0.00
Omnicell (OMCL) United States $1.425B 26.92
Evolent Health (EVH) United States $1.147B 97.70
Claritev (CTEV) United States $0.646B 0.00
Fulgent Genetics (FLGT) United States $0.562B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Talkspace (TALK) United States $0.395B 118.00
Butterfly Network (BFLY) United States $0.354B 0.00
Carlsmed (CARL) $0.344B 0.00
TruBridge (TBRG) United States $0.319B 707.33
Nyxoah SA (NYXH) Belgium $0.255B 0.00
Health Catalyst (HCAT) United States $0.253B 0.00
Zepp Health (ZEPP) Netherlands $0.253B 0.00
Outset Medical (OM) United States $0.251B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.220B 0.00
CapsoVision (CV) United States $0.190B 0.00
KORU Medical Systems (KRMD) United States $0.156B 0.00
MDxHealth SA (MDXH) Belgium $0.117B 0.00
EUDA Health Holdings (EUDA) Singapore $0.113B 0.00
American Well (AMWL) United States $0.110B 0.00
CareCloud (CCLD) United States $0.101B 3.84
ImmunoPrecise Antibodies (IPA) Canada $0.084B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.079B 0.00
Pulmonx (LUNG) United States $0.067B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.034B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
MSP Recovery (MSPR) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00